What Researchers Did
Researchers investigated how a small number of participants in a clinical trial for hyperbaric oxygen therapy for multiple sclerosis evaluated the treatment and decided whether to continue using it after the trial.
What They Found
While clinical trials showed no therapeutic benefit for hyperbaric oxygen therapy in multiple sclerosis, participants continued to use it. The study found that the clinical trial's assumptions about therapeutic benefit differed significantly from the participants' own evaluations and concepts of benefit.
What This Means for Canadian Patients
This study suggests that Canadian patients may evaluate treatments based on personal experiences and perceived benefits, which can differ from the outcomes of formal clinical trials. Healthcare providers should consider patients' perspectives and reasons for continuing therapies, even when scientific evidence of efficacy is lacking.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
The study's findings are based on a small number of participants and may not be generalizable to all patients with multiple sclerosis or other therapies.